Company page
Kiniksa Pharmaceuticals International, Plc
Kiniksa Pharmaceuticals International, Plc (Ticker: KNSA) is a public company based in the United States, specializing in the development of innovative therapies for patients with significant unmet medical needs. The company has a market capitalization of approximately $4.24 billion. Kiniksa focuses on advancing its pipeline of product candidates to address various health conditions.
- Ticker
- KNSA:NASDAQ
- Asset type
- Stock
- Market cap
- $4.24B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD